Sign Up Today and Learn More About PleoPharma Stock
Invest in or calculate the value of your shares in PleoPharma or other pre-IPO companies through EquityZen's platform.
PleoPharma Stock
PleoPharma is a pharmaceutical company that focuses on finding treatments for cannabis related health issues.
About PleoPharma Stock
Founded
2019
Headquarters
Phoenixville, PA, US
Industries
Health Care
PleoPharma Press Mentions
Stay in the know about the latest news on PleoPharma
PleoPharma, Inc. to Present at BIO International Convention 2026
morningstar • Jun 22, 2026
PleoPharma, Inc. to Present at BIO International Convention 2026
prnewswire • Jun 22, 2026
PleoPharma, Inc. Announces First Patient Dosed in Pivotal Phase 3 Clinical Trial of PP-01 (CAN-004) for Mitigation of Cannabis Withdrawal Symptoms in Patients with Cannabis Use Disorder
morningstar • Jun 18, 2026
PleoPharma, Inc. Announces First Patient Dosed in Pivotal Phase 3 Clinical Trial of PP-01 (CAN-004) for Mitigation of Cannabis Withdrawal Symptoms in Patients with Cannabis Use Disorder
prnewswire • Jun 18, 2026
PLEOPHARMA TO PRESENT NEWDATA ON CANNABIS WITHDRAWAL In PATIENTS WITH CANNABIS USE DISORDER AND PHASE 2 PP-01 RESULTS AT THE COLLEGE ON PROBLEMS OF DRUG DEPENDENCE 88TH ANNUAL SCIENTIFIC MEETING
morningstar • Jun 16, 2026
PleoPharma Management
Leadership team at PleoPharma
Director, Co-Founder, and CMO
Jay Constantine
Executive Director
Robert Finizio
Join now and verify your accreditation status to gain access to:
- PleoPharma Current Valuation
- PleoPharma Stock Price
- PleoPharma Management
- Available deals in PleoPharma and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- PleoPharma Cap Table and Funding History by Share Class and Liquidity Preferences
- PleoPharma Revenue and Financials
- PleoPharma Highlights
- PleoPharma Business Model
- PleoPharma Risk Factors
- PleoPharma Research Report from SACRA Research
Trading PleoPharma Stock
How to invest in PleoPharma stock?
Accredited investors can buy pre-IPO stock in companies like PleoPharma through EquityZen funds. These investments are made available by existing PleoPharma shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell PleoPharma stock?
Shareholders can sell their PleoPharma stock through EquityZen's private company marketplace. EquityZen's network includes over 470K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 54K private placements completed across 500+ companies, EquityZen leads the way in delivering "Private Markets for the Public."